Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1986-08-14
1989-01-17
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540477, 540478, 540582, A61K 3155, C07D48708
Patent
active
047988290
ABSTRACT:
Compounds of formula (I) and pharmaceutically acceptable salts thereof: ##STR1## wherein: n is 1, 2, or 3; and m and p are independently 1 or 2 such that m+n+p.gtoreq.4;
REFERENCES:
patent: 3405134 (1968-10-01), Judd
patent: 4612319 (1986-09-01), King
Burger, ed., Medicinal Chemistry 2nd ed., Interscience Pub. (1960), p. 42.
Chemical Abstracts, 82, No. 3, p. 416, 15,805h (1975).
Chemical Abstracts, 74, No. 15, 76,304a (1971).
Chemical Abstracts, 62, No. 11, 13,727f (1965).
Joiner Karen A.
King Francis D.
Barr David K.
Beecham Group plc.
Daus Donald G.
Haley, Jr. James F.
Teoli, Jr. William A.
LandOfFree
1-Azabicyclo[3,2,2]nonane derivatives having 5-HT receptor antag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-Azabicyclo[3,2,2]nonane derivatives having 5-HT receptor antag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-Azabicyclo[3,2,2]nonane derivatives having 5-HT receptor antag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2413599